Overexpression of appoptosin promotes mitochondrial damage in MIN6 cells

Area of Science:

• Cell Biology
• Endocrinology
• Molecular Medicine

Background:

• Pancreatic beta-cell damage is linked to diabetes, with hypoxia a key suspected cause.
• Appoptosin, a mitochondrial protein, is known to induce apoptosis and is upregulated in hypoxic conditions, particularly in neuronal tissues.
• The specific role of appoptosin in pancreatic beta-cells under hypoxic stress is currently unknown.

Purpose of the Study:

• To investigate the function of appoptosin in pancreatic beta-cells under hypoxic conditions.
• To determine if appoptosin plays a role in hypoxia-induced beta-cell apoptosis.
• To explore potential therapeutic targets for protecting beta-cells from hypoxic injury.

Main Methods:

• Mimicking hypoxia using cobalt chloride (CoCl2) in MIN6 mouse insulinoma cells.
• Assessing apoptosis via terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay.
• Evaluating appoptosin expression, mitochondrial damage, and caspase 3 activation using western blotting and reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
• Investigating the effect of appoptosin silencing using short hairpin RNA (shRNA).

Main Results:

• Cobalt chloride treatment induced apoptosis in MIN6 cells.
• Hypoxia activated appoptosin expression, leading to increased mitochondrial damage and caspase 3 activation.
• Silencing appoptosin significantly reduced hypoxia-induced apoptosis in MIN6 cells.
• Appoptosin upregulation exacerbates mitochondrial damage in pancreatic beta-cells under hypoxic stress.

Conclusions:

• Cobalt chloride-induced hypoxia increases appoptosin expression in pancreatic beta-cells.
• Appoptosin activation contributes to mitochondrial damage and apoptosis in beta-cells.
• Inhibiting appoptosin expression presents a potential strategy to enhance pancreatic beta-cell survival, particularly relevant for islet transplantation.